EUVIMEDEUVIMED entdecken
Crossref

BAF312 Inhibits the Growth of Glioma and Promotes the Normalization of Tumor Blood Vessels

Qi Qin iD, Yumei Zhou, Mengzhao Feng, Kaiyuan Zhang, Minkai Wang, Zhenyu Zhang, Min Yu iD, Xianzhi Liu

The FASEB Journal · 2025

DOI: 10.1096/fj.202501098rr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Qi Qin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, China. Hauptthemen laut MEDLINE: Glioma, Brain Neoplasms, Azetidines, Neovascularization, Pathologic. Die Arbeit nennt 26 Literaturangaben. Gefördert von: Science Technology and Innovation Commission of Shenzhen Municipality, National Natural Science Foundation of China, Special Fund for Economic and Technological Development in Longgang District, Shenzhen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study investigates the repurposing of BAF312 (Siponimod), an FDA‐approved sphingosine‐1‐phosphate (S1P) receptor agonist for multiple sclerosis, as a dual‐targeting therapeutic agent for glioma by inhibiting tumor growth and normalizing aberrant tumor vasculature. The clinical correlations between S1PR1/5 expression and glioma prognosis were analyzed using the GEPIA and HPA databases. The effects of BAF312 on tumor growth, cell cycle progression, apoptosis, and vascular remodeling were evaluated using orthotopic GL261 glioma models and glioma cell lines (U118MG, T98G, GL261). Techniques such as bioluminescent imaging, flow cytometry, Western blot analysis, and immunofluorescence staining were employed. High expression of S1PR1/5 was associated with improved survival in glioma patients. BAF312 inhibited glioma proliferation both in vitro and in vivo by arresting the G1‐S transition through modulation of the Skp2‐p27 axis and inducing apoptosis through p53‐independent mitochondrial pathways. Additionally, BAF312 promoted tumor vascular normalization by enhancing pericyte coverage (PDGFRβ + ), reducing vessel leakage (TER119 + RBCs), and altering vessel diameter distribution. Notably, BAF312 reduced CD8 + T cell infiltration, suggesting that its efficacy is predominantly mediated by tumor‐intrinsic mechanisms. BAF312 exhibits significant anti‐glioma activity through mechanisms involving cell cycle arrest, apoptosis induction, and vascular normalization, highlighting its potential as a repurposed therapeutic agent. This study offers preclinical evidence supporting the anti‐glioma effects of BAF312; though further investigation is warranted to evaluate combinatorial efficacy with conventional therapies and address immunosuppressive effects limiting monotherapy application.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaBrain NeoplasmsAzetidinesNeovascularization, PathologicAnimalsHumansMiceCell ProliferationApoptosisCell Line, TumorFemaleSphingosine-1-Phosphate ReceptorsMaleMice, Inbred C57BLXenograft Model Antitumor Assays

Stichwörter der Autor:innen

BAF312S1P receptorgliomatumor growth inhibitiontumor microenvironmenttumor vasculature normalization

Substanzen

AzetidinesSphingosine-1-Phosphate Receptors

Autor:innen und Institutionen

  • Department of Neurosurgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, China.
  • Research Center for Protein and Cell-Based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.

ORCID-Profile: Qi Qin, Min Yu

Förderung

  • Science Technology and Innovation Commission of Shenzhen Municipality
  • National Natural Science Foundation of China
  • Special Fund for Economic and Technological Development in Longgang District, Shenzhen

Zitieren

APA

Qin, Q., Zhou, Y., Feng, M., Zhang, K., Wang, M., Zhang, Z., Yu, M., & Liu, X. (2025). BAF312 Inhibits the Growth of Glioma and Promotes the Normalization of Tumor Blood Vessels. The FASEB Journal. https://doi.org/10.1096/fj.202501098rr

Vancouver

Qin Q, Zhou Y, Feng M, Zhang K, Wang M, Zhang Z, et al. BAF312 Inhibits the Growth of Glioma and Promotes the Normalization of Tumor Blood Vessels. The FASEB Journal. 2025. doi:10.1096/fj.202501098rr

BibTeX
@article{Qin2025,
  author = {Qin, Qi and Zhou, Yumei and Feng, Mengzhao and Zhang, Kaiyuan and Wang, Minkai and Zhang, Zhenyu and Yu, Min and Liu, Xianzhi},
  title = {BAF312 Inhibits the Growth of Glioma and Promotes the Normalization of Tumor Blood Vessels},
  journal = {The FASEB Journal},
  year = {2025},
  doi = {10.1096/fj.202501098rr}
}
Kostenlos starten →